Sign In

Use the Qualified Clinical Data Registry (QCDR) to complete Merit-Based Incentive Payment System reporting.

Report on evidence-based quality measures and receive performance scores via the Quality Oncology Practice Initiative (QOPI®).

Oncology Practice Insider

ASCO’s Oncology Practice Insider provides the latest news, information, and educational tools to assist with the successful management of oncology practice and the delivery of high quality patient care. OPI offers updates on ASCO programs, services, and cancer-related health policy, Medicare news, and billing and coding best practices. To sign up for the biweekly Oncology Practice Insider newsletter, please complete this form.

ASCO is seeking feedback from all members—whether you’re a podcast listener or not—about the Society’s podcast offerings. Please take our ASCO Podcast Survey and share your thoughts to help us improve our podcast program.  
ASCO submitted comments to the Centers for Medicare & Medicaid Services (CMS) in response to a proposed rule that would loosen state reporting requirements and potentially threaten access to cancer care for Medicaid beneficiaries. ASCO believes all patients should have access to high-quality, high-value cancer care and is concerned that CMS’ proposal would jeopardize that access.
The latest ASCO in Action Podcast episode highlights ASCO’s 2019 Advocacy Summit during which oncology care providers from across the United States came to Capitol Hill to urge Members of Congress to support policies that will improve access to high-quality, high-value care for people with cancer. Specifically, ASCO volunteers asked Members of Congress to support:
Register for the October 2019 PracticeNET call. The call is scheduled for October 17, 2019 at 4:00 PM ET. Agenda provided below: 
On September 18, ASCO published the Management of Osteoporosis in Survivors of Adult Cancers With Nonmetastatic Disease Guideline. Clinicians are advised to assess fracture risk using established tools.
Give your patients oncologist-trusted information with ASCO Answers fact sheets, which cover many types of cancer as well as treatments and side effects. Select materials are available to download in 5 languages. ASCO members save 20%. Free domestic shipping. Download Now.
In a recent edition of the CMS Medicare Learning Network, please note for dates of service on or after October 1, use HCPCS code J0642 for levoleucovorin injection products marketed under the brand name of Khapzory.
New study comparing the use of subacute rehabilitation (SAR) instead of hospice referral since the availability of immunotherapy finds a growing number of people with cancer are being discharged to SAR, but approximately two-thirds do not receive further cancer therapy at any point. This research provides important insights for goals of care. Learn more.